-transparent.png){kind=logo}
Oropharyngeal candidiasis (OPC) is the most frequent opportunistic infection associated with HIV infection. Therapies such as topical clotrimazole and nystatin, as well as oral azoles, which had previously been effective prior to the advent of HIV, are increasingly only partially effective in OPC in HIV infection. The effectiveness of oral amphotericin B suspension for OPC is described in 17 HIV-infected patients whose response to other therapies had been unsatisfactory. Three patients yielded isolates of Candida albicans with a minimum inhibitory concentration (MIC) to fluconazole of >/=16 microg/mL. Eleven patients received amphotericin B suspension monotherapy. Of the 17 patients, the symptoms of six resolved entirely, seven patients partially responded, and four failed therapy. These data suggest that amphotericin B suspension may be a useful additional therapy for OPC in HIV-infected patients.
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
December 1996,
Revista clinica espanola,
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
January 1996,
Mycoses,
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
January 2017,
AIDS (London, England),
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
September 2002,
The Annals of pharmacotherapy,
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
September 2004,
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
January 1988,
Clinical pharmacy,
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
February 1973,
Tandlaegebladet,
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
December 1996,
AIDS (London, England),
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
March 2000,
Age and ageing,
S Hood, and
J Evans, and
J Bond, and
E Wilkins, and
D Denning
December 1993,
Journal of acquired immune deficiency syndromes,
